Cosmos Health Inc. (COSM) Form 8-K — Oct 22, 2026
$COSMForm 8-KItems 2.02, 7.01, 9.01Filed Oct 22, 2026, 11:50 AM ET0001477932-26-006396Original filing
Cosmos Health filed an 8-K furnishing a business update with strong preliminary growth metrics: Q4 2026 U.S. revenue of approximately $15 million expected with ~$10.5 million gross profit at a ~70% margin, and active U.S. subscriptions up 42% in five days to 8,940, with >40,000 expected by year-end. The CEO letter reaffirmed full-year 2026 revenue guidance above $90 million (up ~38%), implying Q4 revenue of ~$35.7 million, up ~81% year over year, and laid out fiscal 2029 targets of $200.6 million revenue and $44.2 million adjusted EBITDA.
Key figures
- Revenue
- $54.3 million (preliminary nine-month 2026, up 19% YoY)
- Guidance
- FY2026 revenue >$90 million (up ~38%); Q4 2026 revenue ~$35.7M or more (up ~81%); FY2029: $200.6M revenue, $71.2M gross profit, $44.2M adjusted EBITDA, $31.0M net income; objective of self-funding by 2027
- Revenue Yoy
- 19% (nine months); ~38% full-year 2026 implied
- Cmo pipeline
- >32.7 million units (up sixfold since mid-2024), >$20M implied revenue, ~90% implied gross margin
- Non core assets
- ~$20 million (incl. ~$15M real estate)
- Q3 2026 revenue
- ~$17.4 million (up 40% YoY)
- Year end targets
- >40,000 subscriptions; daily sales >$200,000 (from $60,000)
- Shares repurchased
- 5.1 million shares for ~$1.1 million under $5.0 million program
- Fiscal 2025 revenue
- $65.3 million; gross profit $7.9 million; gross margin 12.1%
- Cosmofarm q2 revenue
- >$15 million (annualized >$60 million, ~4.3x fiscal 2017)
- Online checkout orders
- 14,624 (up 34% from 10,881)
- Active us subscriptions
- 8,940 as of Oct 19, 2026 (up 42% from 6,287 five days earlier)
- Total liabilities change
- down 13.3% from Dec 31, 2025 to Jun 30, 2026
- Monthly subscription value
- $1,325,338 (up 44% from $919,945)
- One time purchases expected
- $3.5 million
- Q4 2026 us revenue expected
- $15 million
- Subscription order attach rate
- 65.2% since inception, >85% of daily orders recently
- Q4 2026 us gross profit expected
- $10.5 million (~70% gross margin)
- Us subscription revenue expected
- $11.5 million (~$8.2M first orders, ~$3.3M renewals)
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.